Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people experience constipation after stopping Mounjaro, and the reason is straightforward: tirzepatide slows the movement of food through the gut, and when that effect lifts, your digestive system needs time to recalibrate. This is a prescription-only medicine, so if bowel changes after stopping are affecting your quality of life, speak to your prescriber rather than managing alone. The full picture of Mounjaro's digestive side effects is worth understanding before and after treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) acts on two gut hormone receptors, GIP and GLP-1, and one of its effects is slowing gastric emptying — food moves more slowly from the stomach into the intestine. That slowing is part of why appetite drops on treatment. When you stop taking it, the brake lifts. For most people that means the gut speeds back up, which can cause loose stools or discomfort. For others, paradoxically, constipation follows.
The reason is that the gut's own signalling has been recalibrating around the medicine. Removing tirzepatide doesn't instantly restore pre-treatment motility; the system overshoots in one direction or another before settling. If your bowels slowed during treatment, that pattern can briefly persist after stopping. If you reduced fibre or fluid intake to manage nausea on Mounjaro, those habits may be compounding the problem now. The NHS tirzepatide medicines page notes constipation as a recognised side effect of the medicine itself, which helps explain why the transition period carries similar risks.
This is not a sign that something has gone wrong permanently. It is a sign that your digestive system is adjusting. Most people find it settles within two to four weeks.
Practical steps matter here more than anything elaborate. Fluid intake is the first lever: aim for water steadily through the day rather than large amounts at once. Fibre helps, but the type matters, soluble fibre from oats, lentils and soft cooked vegetables is gentler than large amounts of raw bran, which can worsen bloating in a sluggish gut.
Gentle movement, even a short walk after meals, supports gut motility in a way that sitting still does not. If you had been eating smaller portions on Mounjaro and your appetite has not yet returned fully, low stool volume can itself cause infrequency, increasing meal size gradually tends to help. The practical guidance on managing constipation during Mounjaro treatment applies largely to the post-treatment window too: many of the same principles hold.
Over-the-counter options such as osmotic laxatives are used for short-term constipation and are generally well tolerated, but check with a pharmacist before adding anything if you are on other medicines. Stimulant laxatives are usually a last resort for short-term use only. Keep a rough note of when bowels last moved and whether there is any pain alongside, that detail matters if you need to speak to a clinician.
Most post-Mounjaro constipation is uncomfortable rather than dangerous. There are, however, symptoms that should prompt you to contact a GP or 111 promptly rather than waiting it out. Severe abdominal pain, particularly pain that radiates toward the back, is one of them. In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a recognised, though infrequent, risk with GLP-1 receptor agonist medicines, and the key symptom is exactly that: severe, persistent stomach pain, with or without vomiting.
Other reasons to seek medical advice: no bowel movement for more than a week despite dietary measures, blood in the stool, unexplained weight loss beyond what the medicine was producing, or significant abdominal distension. These are not typical features of post-Mounjaro constipation and deserve assessment. If you are also seeing other changes after stopping (hair shedding, for instance) the broader picture of side effects when stopping Mounjaro covers several of them together.
If you are unsure whether what you are experiencing is within the expected range of post-treatment adjustment, a conversation with your prescriber is the right move. That is not over-caution; it is exactly what prescriber-led care is for.
Stopping Mounjaro is sometimes planned (end of a course, pregnancy planning, surgery preparation) and sometimes abrupt (supply gap, affordability, a prescriber's advice). The clinical context matters for what comes next. If you stopped because of side effects rather than reaching a treatment goal, that's worth discussing, sometimes a dose reduction rather than stopping resolves tolerability issues, and the side-effect profile at different doses gives useful context on how side effects shift across the titration schedule.
If you are considering restarting or switching to a different approach, our prescribers discuss both suitability and side effects as part of every consultation, including what to expect at transition points. Treatment through nume is reviewed clinically at each stage; a real clinician reads your answers, not software. Current Mounjaro treatment costs and what is included in a private consultation are on our treatment page. If bowel changes like diarrhoea are part of your picture too, the guide to diarrhoea after stopping Mounjaro sits alongside this one. More broadly, our Mounjaro overview covers the medicine's mechanism and licensed use in full.
If you would like to explore what treatment is right for you now, start your free consultation and a GPhC-registered prescriber will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.